Lenvatinib Plus Immunotherapy Versus Lenvatinib Monotherapy in Lenvatinib-Insensitive Patients with Unresectable Hepatocellular Carcinoma: a Retrospective Study
Investigational New Drugs（2025）
Key words
Unresectable hepatocellular carcinoma,Lenvatinib,Immune checkpoint inhibitor,Lenvatinib-insensitive
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined